Merck KGaA: opens new collaboration center in Shanghai

(CercleFinance.com) - MilliporeSigma, the life science and high technology unit of Germany's Merck, today opened a new collaboration center in Shanghai, the company's largest of nine centers worldwide.


The center offers customised solutions and services that help biopharmaceutical and biologics companies improve their processes from drug discovery, development to manufacturing.

At the center, drugmakers can explore innovative techniques and work side-by-side with the company's scientists and engineers to solve process and production challenges.

"With the booming pharmaceutical industry in Asia and greater emphasis on novel drug therapies, we see an increase in R&D on leading-edge treatments including cell and gene therapies in China," said Udit Batra, MilliporeSigma's CEO.

With surface area of approximately 10,000 m2, the company's newest "M Lab" center is located in Pudong, at the heart of the biomedical sciences and research community in Shanghai.

Copyright (c) 2020 CercleFinance.com. All rights reserved.